Lixiana – pharmaceutical daily

Global Anticoagulants Reversal Drugs Market Covering Key Players & Their Competitive Strategies, 2019: Analysis & Outlook Through 2018-2026 – ResearchAndMarkets.com

April 19, 2019April 22, 2019 BusinessWire 0 Comments Anticoagulants, apixaban, dabigatran, edoxaban, Eliquis, Lixiana, Pradaxa, rivaroxaban, Xarelto

The global anticoagulants reversal drugs market expected to expand at aCAGR of 15.3% from 2018 to 2026, owing to the approval of blockbusterdrugs in recent years and strong pipeline driving the market.